We are live on ! Find out more
ORTX

Orchard Therapeutics plc American Depositary Shares
ORTX

Delisted

ORTX was delisted on the 23rd of January, 2024.

Back to rankings

72 hedge funds and large institutions have $265M invested in Orchard Therapeutics plc American Depositary Shares in 2020 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 26 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

8% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 26

11% less funds holding

Funds holding: 81 → 72 (-9)

32% less capital invested

Capital invested by funds: $392M → $265M (-$127M)

47% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 17

75% less call options, than puts

Call options by funds: $63K | Put options by funds: $254K

Holders
72
Holders Change
-9
Holders Change %
-11.11%
% of All Funds
1.45%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
9
Increased
24
Reduced
26
Closed
17
Calls
$63K
Puts
$254K
Net Calls
-$191K
Net Calls Change
-$191K

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$9.88M
2
JP Morgan Chase
JP Morgan Chase
New York
+$5.59M
3
Artisan Partners
Artisan Partners
Wisconsin
+$4.17M
4
CC
Casdin Capital
New York
+$1.14M
5
Millennium Management
Millennium Management
New York
+$739K

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$9.41M
2
Citadel Advisors
Citadel Advisors
Florida
-$6.89M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$5.17M
4
Renaissance Technologies
Renaissance Technologies
New York
-$3.05M
5
ACH
ArrowMark Colorado Holdings
Colorado
-$2.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
MC
51
Matisse Capital
Oregon
$58K +$72.4K +1,400 New
IAA
52
Ironsides Asset Advisors
North Carolina
$52K +$4.34K +84 +7%
GCP
53
GSA Capital Partners
United Kingdom
$47K -$48.4K -936 -45%
Zurich Cantonal Bank
54
Zurich Cantonal Bank
Switzerland
$47K – – –
APA
55
American Portfolios Advisors
New York
$24.8K +$20.7K +400 +197%
Citigroup
56
Citigroup
New York
$24K +$2.79K +54 +10%
UBS Group
57
UBS Group
Switzerland
$16K +$103 +2 +0.5%
AA
58
AlphaCentric Advisors
Puerto Rico
$12K -$3.62K -70 -19%
Group One Trading
59
Group One Trading
Illinois
$11K +$13.7K +265 New
Barclays
60
Barclays
United Kingdom
$8K +$10.3K +200 +1,667%
TRCT
61
Tower Research Capital (TRC)
New York
$7K -$2.43K -47 -21%
Wells Fargo
62
Wells Fargo
California
$7K +$5.48K +106 +151%
Simplex Trading
63
Simplex Trading
Illinois
$5K +$6.51K +126 +1,050%
Osaic Holdings
64
Osaic Holdings
Arizona
$2K +$1.96K +38 +475%
PCM
65
Penserra Capital Management
California
$2K +$2.64K +51 New
Royal Bank of Canada
66
Royal Bank of Canada
Ontario, Canada
$2K +$2.95K +57 New
Millennium Management
67
Millennium Management
New York
$1.49K +$739K +14,297 +65%
Daiwa Securities Group
68
Daiwa Securities Group
Japan
$1K – – –
Northwestern Mutual Wealth Management
69
Northwestern Mutual Wealth Management
Wisconsin
$1K +$982 +19 New
EWM
70
Edge Wealth Management
New York
$1K +$1.14K +22 New
AWM
71
AllSquare Wealth Management
New York
$1K +$1.81K +35 New
ACH
72
ArrowMark Colorado Holdings
Colorado
– -$2.65M -44,080 Closed
Two Sigma Investments
73
Two Sigma Investments
New York
– -$437K -7,275 Closed
Marshall Wace
74
Marshall Wace
United Kingdom
– -$399K -6,642 Closed
PPA
75
Parametric Portfolio Associates
Washington
– -$353K -5,890 Closed
1 2
3
4

ORTX Hedge Fund Activity: Q3 2020 in Review

72 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Orchard Therapeutics plc American Depositary Shares (ORTX) for Q3 2020, worth a combined $265M — down 32% from $392M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of ORTX and 9 opened new positions — a net loss of 8 holders — while 26 trimmed existing stakes and 24 added.

The largest buyer was RA Capital Management, adding an estimated $9.88M. The largest seller was T. Rowe Price Associates, cutting an estimated $9.41M.

  • 72 institutional investors held Orchard Therapeutics plc American Depositary Shares (ORTX) as of Q3 2020, down from 81 in Q2 2020.
  • Funds reported $265M of Orchard Therapeutics plc American Depositary Shares stock for Q3 2020, down 32% quarter-over-quarter.
  • 9 funds opened new Orchard Therapeutics plc American Depositary Shares positions in Q3 2020 and 17 closed out, a net change of -8 holders.
  • The largest Orchard Therapeutics plc American Depositary Shares buyer in Q3 2020 was RA Capital Management, an estimated $9.88M added.
  • The largest Orchard Therapeutics plc American Depositary Shares seller in Q3 2020 was T. Rowe Price Associates, an estimated $9.41M sold.

Based on aggregated 13F filings for Q3 2020.